Free Trial

Polarean Imaging (POLX) Competitors

Polarean Imaging logo
GBX 1.14 0.00 (0.00%)
As of 10:06 AM Eastern

POLX vs. CREO, IUG, NCYT, IHC, AVO, MHC, RUA, SUN, BELL, and DEMG

Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry.

Polarean Imaging vs.

Polarean Imaging (LON:POLX) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, community ranking, dividends, risk and analyst recommendations.

Creo Medical Group has a net margin of -73.93% compared to Polarean Imaging's net margin of -1,333.97%. Creo Medical Group's return on equity of -41.79% beat Polarean Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Polarean Imaging-1,333.97% -86.11% -32.28%
Creo Medical Group -73.93%-41.79%-20.09%

Creo Medical Group has higher revenue and earnings than Polarean Imaging. Creo Medical Group is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Polarean Imaging£5.21M3.21-£69.44M-£3.89-0.29
Creo Medical Group£33.87M1.55-£25.04M-£6.32-2.06

Creo Medical Group received 83 more outperform votes than Polarean Imaging when rated by MarketBeat users. However, 67.65% of users gave Polarean Imaging an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote.

CompanyUnderperformOutperform
Polarean ImagingOutperform Votes
23
67.65%
Underperform Votes
11
32.35%
Creo Medical GroupOutperform Votes
106
67.52%
Underperform Votes
51
32.48%

12.1% of Polarean Imaging shares are held by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are held by institutional investors. 39.3% of Polarean Imaging shares are held by company insiders. Comparatively, 22.4% of Creo Medical Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Polarean Imaging has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

In the previous week, Creo Medical Group had 2 more articles in the media than Polarean Imaging. MarketBeat recorded 2 mentions for Creo Medical Group and 0 mentions for Polarean Imaging. Creo Medical Group's average media sentiment score of 0.17 beat Polarean Imaging's score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
Polarean Imaging Neutral
Creo Medical Group Neutral

Summary

Creo Medical Group beats Polarean Imaging on 10 of the 15 factors compared between the two stocks.

Remove Ads
Get Polarean Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POLX vs. The Competition

MetricPolarean ImagingMedical Devices IndustryMedical SectorLON Exchange
Market Cap£16.70M£3.56B£5.59B£2.57B
Dividend YieldN/A2.44%5.33%4.92%
P/E Ratio-0.2979.7923.48137.92
Price / Sales3.21130.54374.79268,680.80
Price / Cash4.9315.9938.1728.07
Price / Book0.343.816.734.52
Net Income-£69.44M£126.02M£3.20B£5.79B
7 Day Performance-5.17%-3.05%-5.36%-0.45%
1 Month Performance-15.70%-6.58%-0.10%5.23%
1 Year Performance-73.53%-12.38%8.09%31.20%

Polarean Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POLX
Polarean Imaging
N/AGBX 1.14
flat
N/A-73.5%£16.70M£5.21M-0.2928
CREO
Creo Medical Group
N/AGBX 12.88
+0.6%
N/A-62.0%£52.05M£33.87M-2.04279
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57M-18.9165
NCYT
Novacyt
N/AGBX 45.31
-7.5%
N/A-6.8%£31.31M£18.12M-0.83120Gap Down
IHC
Inspiration Healthcare Group
N/AGBX 16.37
-2.3%
N/A-41.8%£14.18M£42.87M-1.12224Gap Down
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
MHC
MyHealthChecked
N/AGBX 15
-3.2%
N/A+17.9%£7.81M£9.43M-7.4816Gap Up
RUA
RUA Life Sciences
N/AGBX 12.08
-1.4%
N/A+29.2%£7.49M£4.05M-2.8148
SUN
Surgical Innovations Group
N/AGBX 0.55
+0.2%
N/A+13.0%£5.14M£12.54M-21.1180
BELL
Belluscura
N/AGBX 1.60
-3.0%
N/A-91.8%£4.03M£2.87M-0.1724Gap Down
DEMG
Deltex Medical Group
N/AGBX 0.01
-71.4%
N/AN/A£187,000.00£1.76M-0.1537Gap Up
High Trading Volume
Remove Ads

Related Companies and Tools


This page (LON:POLX) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners